$14.7914.79 +0.540.54 |(+3.793.79 %)
52W H: 2752W L: 13.75Beta: 0.26
About Kardigan Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: http://www.kardigan.bio
Frequently Asked Questions
What is the 52-week range for KARD?
The 52-week high is $27 and the 52-week low is $13.75.
What is the P/E ratio for KARD?
The P/E ratio data is currently unavailable.
What is the dividend yield for KARD?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
ROE data is currently unavailable.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for KARD over the last few months:
2026-09-01
Buy: 5
S.Buy: 4
Hold: 1
Sell: 0
2026-08-01
Buy: 5
S.Buy: 4
Hold: 1
Sell: 0
Latest KARD News
Kardigan Announces Appointment of Kristin Reinke to its Board of Directors
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J., September 30, 2026--Kardigan announced today the appointment of Kristin Reinke to its Board of Directors, where she will serve as chair of the Audit Committee.
Yahoo9/30/2026
Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification
Kardigan outlook: biology-driven programs for genetic DCM, CAVS & ASH; $660.7M runway; and key 2027 catalysts. Click for more on KARD stock.
SeekingAlpha9/13/2026
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-29 | Reinke Kristin Marie K | +48,368 | - | - |
| 2026-06-17 | PERCEPTIVE ADVISORS LLC | +20,706 | - | - |